Author:
Li Rui,Sun Xiaobo,Shu Yaqing,Mao Zhifeng,Xiao Li,Qiu Wei,Lu Zhengqi,Hu Xueqiang
Funder
Medical Scientific Research Foundation of Guangdong Province
Science Foundation of Guangdong Province
National Science Foundation of China
Subject
Neurology (clinical),Neurology,General Medicine
Reference28 articles.
1. Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis;Andersen;J. Neurol. Neurosurg. Psychiat.,2004
2. Sex and gender subgroup analyses of randomized trials;Aulakh;Womens Health Issues,2007
3. Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study;Bar-Or;J. Neurol.,2013
4. Sexual disparities in the incidence and course of MS;Bove;Clin. Immunol.,2013
5. Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes;Coles;Lancet Neurol.,2011
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献